Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
Muna Therapeutics has raised $1.0M in total funding. The most recent round was Grant. The last funding was announced in January 2026.
Muna Therapeutics's investors include Sofinnova Partners, Michael J. Fox Foundation, Sanofi Ventures, Polaris Partners, Novo Holdings.
Muna Therapeutics is headquartered in Copenhagen, Denmark.
Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
Muna Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Muna Therapeutics — Funding & Investors." VCBacked, January 8, 2026, https://www.vcbacked.co/company/muna-therapeutics. Accessed August 1, 2026.
VCBacked. (2026). Muna Therapeutics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/muna-therapeutics
{{cite web |title=Muna Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/muna-therapeutics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated